Answer
UK studies reported 93% effectiveness against pertussis after maternal REPEVAX vaccination in the third trimester of pregnancy: 95% CI 81–97% over infants’ first two months and 89–95% over their first three months.
Sources for this answer
- REPEVAXSANOFI · emc · SmPC §5.1 Pharmacodynamic properties · Version 26Document updated
Sources checked